PeriGen® to Showcase AI-Powered Fetal and Maternal Early Warning Solution at HIMSS18 - Printable Version +- HIStalk Sponsor Announcements (https://histalk.com/forum) +-- Forum: Sponsor News (https://histalk.com/forum/forumdisplay.php?fid=1) +--- Forum: Announcements (https://histalk.com/forum/forumdisplay.php?fid=2) +--- Thread: PeriGen® to Showcase AI-Powered Fetal and Maternal Early Warning Solution at HIMSS18 (/showthread.php?tid=386)

PeriGen® to Showcase AI-Powered Fetal and Maternal Early Warning Solution at HIMSS18 - Margaret Kelly - 03-06-2018   FOR IMMEDIATE RELEASE   PeriGen[sup]®[/sup] to Showcase Artificial Intelligence-Powered Fetal and Maternal Early Warning Solution at HIMSS18   PeriWatch™ Vigilance™ leverages enhanced data analysis and pertinent, customizable notifications enabling faster, more informed interventions   LAS VEGAS — HIMSS Conference — March 5, 2018 — PeriGen, an innovator of perinatal early warning systems, today announced that it will deliver a sneak peek of PeriWatch™ Vigilance™, a new fetal and maternal early warning platform, at the health information technology industry’s premier annual conference, HIMSS18, taking place March 5-9, in Las Vegas. The company will showcase this new technology at the Qualcomm Life booth, #3854.   PeriWatch™ Vigilance™ is a new early warning platform for obstetrics that automatically identifies patients whose conditions are worsening, facilitating more timely interventions. Vigilance augments currently installed fetal surveillance systems, providing a critical layer of patient safety without requiring a hospital to “rip and replace” current systems. The “always on” software uses proprietary intelligent algorithms to analyze maternal vital signs, fetal heart rate, contractions and labor progress in real time, informing clinicians of emerging abnormalities. Specific thresholds and automated checklists can be configured according to each institution’s preferences.    “Delayed response to clinical warning signs is by far the leading human factor found in severe birth-related morbidity,” said Matthew Sappern, CEO of PeriGen. “The tireless analyses performed by PeriWatch™ Vigilance™ help clinicians see worrisome trends at a glance, and intervene before it is too late. Use of early warning systems as well as the PeriWatch modules has been associated with a reduction in morbidity.”    PeriWatch Vigilance is an enterprise-wide platform that is simple to implement and augments current fetal surveillance systems, providing a critical layer of patient safety with minimal IT investment and management. Automated analysis and clear patient identification of worsening conditions are essential for centers providing virtual clinical support for hundreds of remote sites.   PeriGen recently entered into a strategic reseller agreement with Qualcomm Incorporated (NASDAQ:QCOM), through its wholly owned subsidiary, Qualcomm Life, Inc. To learn more, please visit PeriGen executives at the Qualcomm Life booth, #3854 or e-mail info@perigen.com.   About PeriGen PeriGen offers innovative perinatal software solutions that incorporates artificial intelligence (AI) to enhance clinical efficiency and standardization of care during childbirth. Led by skilled OB practitioners and IT visionaries, PeriGen has created the PeriWatch platform to provide consistent analysis and efficient display of complex data in real-time to promote better human recognition and communication about impending problems during labor. With PeriWatch clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation. To learn more, visit www.perigen.com; follow us on Twitter, LinkedIn, YouTube, and Facebook; or call 984.208.4250 or email.   ### Media Contact:                                                                      Heather Caouette                                                                                                                Amendola Communications for PeriGen                                                        Phone: 508-579-3894                                                                                           Email: hcaouette@acmarketingpr.com